PubMed

Cost-effectiveness in hepatitis B.

Weitzman G, Jacobson I.

Ann Intern Med. 2005 Nov 15;143(10):757-8; author reply 758-9. No abstract available. PMID: 16287803 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.

[No authors listed]

Ann Intern Med. 2005 May 17;142(10):I39. No abstract available. PMID: 15897528 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM.

Ann Intern Med. 2005 May 17;142(10):821-31.PMID: 15897532 [PubMed - indexed for MEDLINE]Related articlesFree article

Assessing the benefits and costs of new therapies for hepatitis B virus infection.

Owens DK, Black M.

Ann Intern Med. 2005 May 17;142(10):863-4. No abstract available. PMID: 15897538 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B.

Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R.

Aliment Pharmacol Ther. 2006 Feb 1;23(3):409-19.PMID: 16423000 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

Veenstra DL, Sullivan SD, Clarke L, Iloeje UH, Tafesse E, Di Bisceglie A, Kowdley KV, Gish RG.

Pharmacoeconomics. 2007;25(11):963-77.PMID: 17960954 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.

Lacey LF, Gane E.

J Viral Hepat. 2007 Nov;14(11):751-66.PMID: 17927611 [PubMed - indexed for MEDLINE]Related articlesFree article

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

[Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea]

Kim BK, Kwon SY, Lee CH, Choe WH, Choi HM, Koo HW.

Korean J Hepatol. 2009 Mar;15(1):25-41. Korean. PMID: 19346783 [PubMed - indexed for MEDLINE]Related articlesFree article

A systematic review and economic evaluation of adefovir dipivoxil and pegylated interferon-alpha-2a for the treatment of chronic hepatitis B.

Takeda A, Jones J, Shepherd J, Davidson P, Price A.

J Viral Hepat. 2007 Feb;14(2):75-88. Review.PMID: 17244247 [PubMed - indexed for MEDLINE]Related articles

Economic evaluation of chronic hepatitis B treatments in Taiwan.

Lacey L, Chien RN, Chuang WL, Pwu RF.

J Gastroenterol Hepatol. 2008 Apr;23(4):571-9.PMID: 18397486 [PubMed - indexed for MEDLINE]Related articles

[Chronic hepatitis B: which patients should be treated and how?]

Asselah T, Ripault MP, Marcellin P.

Gastroenterol Clin Biol. 2005 Apr;29(4):374-83. Review. French. No abstract available. PMID: 15864198 [PubMed - indexed for MEDLINE]Related articles

Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis.

Veenstra DL, Spackman DE, Di Bisceglie A, Kowdley KV, Gish RG.

Aliment Pharmacol Ther. 2008 Jun;27(12):1240-52. Epub 2008 Mar 27. Review. Erratum in: Aliment Pharmacol Ther.2008 Jul;28(1): 166. Bisceglie, A [corrected to Di Bisceglie, A]. PMID: 18373637 [PubMed - indexed for MEDLINE]Related articles

[Pharmacological agents for the treatment of chronic hepatitis B]

Sánchez-Tapias JM.

Gastroenterol Hepatol. 2008 Mar;31(3):120-8. Review. Spanish. No abstract available. PMID: 18341843 [PubMed - indexed for MEDLINE]Related articles

Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: a systematic review of economic evidence.

Sun X, Qin WX, Li YP, Jiang XH.

J Gastroenterol Hepatol. 2007 Sep;22(9):1369-77. Review.PMID: 17716343 [PubMed - indexed for MEDLINE]Related articles

The maze of treatments for hepatitis B.

Lok AS.

N Engl J Med. 2005 Jun 30;352(26):2743-6. No abstract available. PMID: 15987924 [PubMed - indexed for MEDLINE]Related articles

[Advances in treatment of chronic hepatitis B.]

Chen Z.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 Mar;34(2):95-7. Chinese. No abstract available. PMID: 15812879 [PubMed - indexed for MEDLINE]Related articles

[An attempt to approach an optional therapeutic regimen for chronic hepatitis B]

Zhang DF.

Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):577-81. Chinese. No abstract available. PMID: 15504284 [PubMed - indexed for MEDLINE]Related articles

[Protocol for the antiviral therapy of chronic hepatitis B]

Gasztroenterológiai Szakmai Kollégium; Infektológiai Szakmai Kollégium.

Orv Hetil. 2008 Dec 7;149(49):2341-3. Hungarian. No abstract available. PMID: 19042187 [PubMed - indexed for MEDLINE]Related articles

Current treatment of chronic hepatitis B.

Montazeri G.

Arch Iran Med. 2006 Jan;9(1):1-10. Review.PMID: 16649370 [PubMed - indexed for MEDLINE]Related articles